Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778206 · ClinicalTrials.gov registry record
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
A clinical trial, sponsored by BioMarin Pharmaceutical.
- Completed
- Registry status
- 1,887
- Enrollment target
NCT00778206 is a clinical trial that has completed, run by BioMarin Pharmaceutical. The registered enrollment target is 1,887 participants.
The verdict
NCT00778206 has completed, sponsored by BioMarin Pharmaceutical.
- COMPLETED
- Registry status
- 1,887 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety of long-term treatment with Kuvan.
Interventions
- DRUG Kuvan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,887 participants |
| Start Date | 2008-09 |
| Est. Completion | 2021-01-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00778206
The ClinicalTrials.gov registry entry for NCT00778206 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,887 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMarin Pharmaceutical, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kuvan is the first listed.
NCT00778206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00778206 about?
NCT00778206 is a clinical study titled "PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry". The objective of this study is to evaluate the safety of long-term treatment with Kuvan.
What is the current status of trial NCT00778206?
This trial is currently completed. The enrollment target is 1,887 participants. The study started on 2008-09. Estimated completion is 2021-01-29.
What interventions are being tested in trial NCT00778206?
The interventions under investigation include: Kuvan (DRUG).
Who is sponsoring clinical trial NCT00778206?
This trial is sponsored by BioMarin Pharmaceutical, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.